Cargando…
Inhibitory Effect of Polyclonal Antibodies Against HER3 Extracellular Subdomains on Breast Cancer Cell Lines
OBJECTIVE: Human epidermal growth factor receptor 3 (HER3) is a unique member of the tyrosine kinase receptors with an inactive kinase domain and is the preferable dimerization partner for HER2 which lead to potent tumorigenic signaling. METHODS: In this study, the expression plasmids coding for the...
Autores principales: | Mansouri-Fard, Samaneh, Ghaedi, Mojgan, Shokri, Mohammad-Reza, Bahadori, Tannaz, Khoshnoodi, Jalal, Golsaz-Shirazi, Forough, Jeddi-Tehrani, Mahmood, Amiri, Mohammad Mehdi, Shokri, Fazel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332115/ https://www.ncbi.nlm.nih.gov/pubmed/32102522 http://dx.doi.org/10.31557/APJCP.2020.21.2.439 |
Ejemplares similares
-
Characterization of Monoclonal and Polyclonal Antibodies Recognizing Prostate Specific Antigen: Implication for Design of a Sandwich ELISA
por: Raoofi Mohseni, Sahar, et al.
Publicado: (2019) -
Epitope Mapping of Human HER2 Specific Mouse Monoclonal Antibodies Using Recombinant Extracellular Subdomains
por: Ghatar, Reza Hosseini, et al.
Publicado: (2017) -
Differential Effects of Inhibitory and Stimulatory Anti-HER2 Monoclonal Antibodies on AKT/ERK Signaling Pathways
por: Soltantoyeh, Tahereh, et al.
Publicado: (2018) -
Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model
por: Hassannia, Hadi, et al.
Publicado: (2022) -
A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo
por: Mohammadi, Mehdi, et al.
Publicado: (2021)